They will provide specific instructions, which typically involve stopping the medication a certain number of days before surgery
When tirzepatide is used with other glucose-lowering drugs such as insulin or sulfonylurea, the medication may increase the risk of hypoglycemia (low blood sugar level)
A thorough history, physical examination, and targeted investigations based on clinical presentation are essential to identify the underlying cause
Diarrhea, vomiting, decreased appetite, constipation, and abdominal pain are all documented
The most rapid weight loss usually occurs during months two through six as doses increase and the medication reaches full therapeutic effect
Foods that trigger semaglutide burping Diet is the single most controllable factor in semaglutide-related burping